FDA Inspection 1018165 — Department of Defense - Army (Armed Services Blood Program)

Department of Defense - Army (Armed Services Blood Program) — FEI 3002964709

The FDA completed an inspection of Department of Defense - Army (Armed Services Blood Program) on May 25, 2017 in Landstuhl. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 25, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Landstuhl (Germany)